Cancer Research Technology
Log in Register
Menu

Anti-Factor VII, Recombinant [RFF-VII/1]

Info

Catalogue Number 153357
Applications ELISA Fn WB
Antigen/Gene or Protein Targets Factor VII
Reactivity Human
Relevance Factor VII is a 50kDa multi-domain, single chain plasma glycoprotein synthesised in the liver. It is essential for blood coagulation. Factor VII is converted to the active, two chain, serine protease Factor VIIa via cleavage by thrombin, factor Xa, factor IXa or factor XIIa. Factor VIIa converts factor X to factor Xa, which in turn converts prothrombin to thrombin. This monoclonal antibody partially inhibits human Factor VII activity.
Host Mouse
Immunogen Purified human factor VII
Subclass IgG1 kappa
Formulation PBS
Concentration 1mg/ml
Research Area Cardiovascular
Notes Recombinant monoclonal antibody produced from the original monoclonal. Manufactured using Absolute Antibody’s Recombinant Platform with variable regions (i.e. specificity) from the hybridoma.

References

There are 1 reference entries for this reagent.

View All References

References: 1 entry

Original hybridoma first published in: Takase et al. 1988. J Clin Pathol. 41(3):337-41. PMID: 3360957.


Add a reference

References: 1 entry

Original hybridoma first published in: Takase et al. 1988. J Clin Pathol. 41(3):337-41. PMID: 3360957.


Add a reference

Inventor Information